Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

LAMICTAL (Lamotrigine) For The Treatment Of Absence Seizures
Evaluation of Lamotrigine in Subjects With Absence Seizures
Status: Enrolling
Updated:  9/27/2017
GSK Investigational Site
mi
from
Milwaukee, WI
LAMICTAL (Lamotrigine) For The Treatment Of Absence Seizures
Evaluation of Lamotrigine in Subjects With Absence Seizures
Status: Enrolling
Updated: 9/27/2017
GSK Investigational Site
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)
A Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Systemic Sclerosis
Status: Enrolling
Updated:  9/28/2017
Stanford University School of Medicine
mi
from
Stanford, CA
A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)
A Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Systemic Sclerosis
Status: Enrolling
Updated: 9/28/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Status: Enrolling
Updated:  9/28/2017
University of Arkansas
mi
from
Fayetteville, AR
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Status: Enrolling
Updated: 9/28/2017
University of Arkansas
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Status: Enrolling
Updated:  9/28/2017
University of Connecticut
mi
from
Storrs, CT
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Status: Enrolling
Updated: 9/28/2017
University of Connecticut
mi
from
Storrs, CT
Click here to add this to my saved trials
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Status: Enrolling
Updated:  9/28/2017
SUNY Upstate Medical University
mi
from
Syracuse, NY
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Status: Enrolling
Updated: 9/28/2017
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Status: Enrolling
Updated:  9/28/2017
University of South Carolina
mi
from
Columbia, SC
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Status: Enrolling
Updated: 9/28/2017
University of South Carolina
mi
from
Columbia, SC
Click here to add this to my saved trials
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Status: Enrolling
Updated:  9/28/2017
University of Texas at Austin
mi
from
Austin, TX
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Status: Enrolling
Updated: 9/28/2017
University of Texas at Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Status: Enrolling
Updated:  9/28/2017
Baylor College of Medicine
mi
from
Houston, TX
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Status: Enrolling
Updated: 9/28/2017
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Status: Enrolling
Updated:  9/28/2017
Houston Methodist Hospital
mi
from
Houston, TX
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Status: Enrolling
Updated: 9/28/2017
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Status: Enrolling
Updated:  9/28/2017
Michigan State University
mi
from
East Lansing, MI
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Status: Enrolling
Updated: 9/28/2017
Michigan State University
mi
from
East Lansing, MI
Click here to add this to my saved trials
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Status: Enrolling
Updated:  9/28/2017
University of New Mexico
mi
from
Albuquerque, NM
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization
Status: Enrolling
Updated: 9/28/2017
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization in High School Athletes
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization in High School Athletes
Status: Enrolling
Updated:  9/28/2017
Michigan State University
mi
from
East Lansing, MI
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization in High School Athletes
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization in High School Athletes
Status: Enrolling
Updated: 9/28/2017
Michigan State University
mi
from
East Lansing, MI
Click here to add this to my saved trials
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization in High School Athletes
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization in High School Athletes
Status: Enrolling
Updated:  9/28/2017
Baylor College of Medicine
mi
from
Houston, TX
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization in High School Athletes
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization in High School Athletes
Status: Enrolling
Updated: 9/28/2017
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Proof of Concept (POC) in Patients With Ischaemic Stroke
Study MAG104615, a Proof of Concept Study for GSK249320 Versus Placebo in Stroke Patients
Status: Enrolling
Updated:  9/29/2017
GSK Investigational Site
mi
from
Orange, CA
Proof of Concept (POC) in Patients With Ischaemic Stroke
Study MAG104615, a Proof of Concept Study for GSK249320 Versus Placebo in Stroke Patients
Status: Enrolling
Updated: 9/29/2017
GSK Investigational Site
mi
from
Orange, CA
Click here to add this to my saved trials
Proof of Concept (POC) in Patients With Ischaemic Stroke
Study MAG104615, a Proof of Concept Study for GSK249320 Versus Placebo in Stroke Patients
Status: Enrolling
Updated:  9/29/2017
GSK Investigational Site
mi
from
Jacksonville, FL
Proof of Concept (POC) in Patients With Ischaemic Stroke
Study MAG104615, a Proof of Concept Study for GSK249320 Versus Placebo in Stroke Patients
Status: Enrolling
Updated: 9/29/2017
GSK Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Proof of Concept (POC) in Patients With Ischaemic Stroke
Study MAG104615, a Proof of Concept Study for GSK249320 Versus Placebo in Stroke Patients
Status: Enrolling
Updated:  9/29/2017
GSK Investigational Site
mi
from
Peoria, IL
Proof of Concept (POC) in Patients With Ischaemic Stroke
Study MAG104615, a Proof of Concept Study for GSK249320 Versus Placebo in Stroke Patients
Status: Enrolling
Updated: 9/29/2017
GSK Investigational Site
mi
from
Peoria, IL
Click here to add this to my saved trials
Proof of Concept (POC) in Patients With Ischaemic Stroke
Study MAG104615, a Proof of Concept Study for GSK249320 Versus Placebo in Stroke Patients
Status: Enrolling
Updated:  9/29/2017
GSK Investigational Site
mi
from
Lexington, KY
Proof of Concept (POC) in Patients With Ischaemic Stroke
Study MAG104615, a Proof of Concept Study for GSK249320 Versus Placebo in Stroke Patients
Status: Enrolling
Updated: 9/29/2017
GSK Investigational Site
mi
from
Lexington, KY
Click here to add this to my saved trials
Proof of Concept (POC) in Patients With Ischaemic Stroke
Study MAG104615, a Proof of Concept Study for GSK249320 Versus Placebo in Stroke Patients
Status: Enrolling
Updated:  9/29/2017
GSK Investigational Site
mi
from
Portland, OR
Proof of Concept (POC) in Patients With Ischaemic Stroke
Study MAG104615, a Proof of Concept Study for GSK249320 Versus Placebo in Stroke Patients
Status: Enrolling
Updated: 9/29/2017
GSK Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Proof of Concept (POC) in Patients With Ischaemic Stroke
Study MAG104615, a Proof of Concept Study for GSK249320 Versus Placebo in Stroke Patients
Status: Enrolling
Updated:  9/29/2017
GSK Investigational Site
mi
from
Nashville, TN
Proof of Concept (POC) in Patients With Ischaemic Stroke
Study MAG104615, a Proof of Concept Study for GSK249320 Versus Placebo in Stroke Patients
Status: Enrolling
Updated: 9/29/2017
GSK Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Proof of Concept (POC) in Patients With Ischaemic Stroke
Study MAG104615, a Proof of Concept Study for GSK249320 Versus Placebo in Stroke Patients
Status: Enrolling
Updated:  9/29/2017
GSK Investigational Site
mi
from
Edmonton,
Proof of Concept (POC) in Patients With Ischaemic Stroke
Study MAG104615, a Proof of Concept Study for GSK249320 Versus Placebo in Stroke Patients
Status: Enrolling
Updated: 9/29/2017
GSK Investigational Site
mi
from
Edmonton,
Click here to add this to my saved trials
ADAPT A Direct Aspiration, First Pass Technique for the Endovascular Treatment of Stroke
ADAPT A Direct Aspiration, First Pass Technique for the Endovascular Treatment of Stroke
Status: Enrolling
Updated:  9/29/2017
MUSC
mi
from
Charleston, SC
ADAPT A Direct Aspiration, First Pass Technique for the Endovascular Treatment of Stroke
ADAPT A Direct Aspiration, First Pass Technique for the Endovascular Treatment of Stroke
Status: Enrolling
Updated: 9/29/2017
MUSC
mi
from
Charleston, SC
Click here to add this to my saved trials
tDCS in Cervical Dystonia
Optimizing tDCS in Cervical Dystonia
Status: Enrolling
Updated:  9/29/2017
Univ of Minnesota
mi
from
Minneapolis, MN
tDCS in Cervical Dystonia
Optimizing tDCS in Cervical Dystonia
Status: Enrolling
Updated: 9/29/2017
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Transcranial Direct Current Stimulation (tDCS) in Chronic Post-Stroke Apathy
Transcranial Direct Current Stimulation (tDCS) in Chronic Post-Stroke Apathy
Status: Enrolling
Updated:  9/29/2017
Stony Brook University
mi
from
Stony Brook, NY
Transcranial Direct Current Stimulation (tDCS) in Chronic Post-Stroke Apathy
Transcranial Direct Current Stimulation (tDCS) in Chronic Post-Stroke Apathy
Status: Enrolling
Updated: 9/29/2017
Stony Brook University
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Nilotinib in the Treatment of Systemic Sclerosis
Phase IIA Study of the Safety and Tolerability of the Use of Nilotinib in the Treatment of Systemic Sclerosis
Status: Enrolling
Updated:  10/2/2017
Hospital for Special Surgery
mi
from
New York, NY
Nilotinib in the Treatment of Systemic Sclerosis
Phase IIA Study of the Safety and Tolerability of the Use of Nilotinib in the Treatment of Systemic Sclerosis
Status: Enrolling
Updated: 10/2/2017
Hospital for Special Surgery
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of an Oxalate Strip on Adjacent Teeth With Dentinal Hypersensitivity
A Pilot Clinical Study to Evaluate the Safety and Efficacy of a Self-Applied Oxalate Strip on Adjacent Teeth With Dentinal Hypersensitivity
Status: Enrolling
Updated:  10/2/2017
Oral Health Science Center
mi
from
Mason, OH
A Study to Evaluate the Safety and Efficacy of an Oxalate Strip on Adjacent Teeth With Dentinal Hypersensitivity
A Pilot Clinical Study to Evaluate the Safety and Efficacy of a Self-Applied Oxalate Strip on Adjacent Teeth With Dentinal Hypersensitivity
Status: Enrolling
Updated: 10/2/2017
Oral Health Science Center
mi
from
Mason, OH
Click here to add this to my saved trials
Electrical Stimulation for Recovery of Hand Function in Chronic Stroke Survivors
Contralaterally Controlled FES for Chronic Arm/Hand Hemiplegia: Single-Site RCT
Status: Enrolling
Updated:  10/3/2017
MetroHealth Med Ctr
mi
from
Cleveland, OH
Electrical Stimulation for Recovery of Hand Function in Chronic Stroke Survivors
Contralaterally Controlled FES for Chronic Arm/Hand Hemiplegia: Single-Site RCT
Status: Enrolling
Updated: 10/3/2017
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials
Melatonin and Sleep in Preventing Delirium in the Hospital
Melatonin and Sleep in Preventing Delirium in the Hospital: A Randomized Placebo-controlled Trial
Status: Enrolling
Updated:  10/3/2017
Scripps Green Hospital
mi
from
La Jolla, CA
Melatonin and Sleep in Preventing Delirium in the Hospital
Melatonin and Sleep in Preventing Delirium in the Hospital: A Randomized Placebo-controlled Trial
Status: Enrolling
Updated: 10/3/2017
Scripps Green Hospital
mi
from
La Jolla, CA
Click here to add this to my saved trials
Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking and Quality of Life in MS
Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking Performance and Quality of Life in Individuals With Multiple Sclerosis: A Pilot Study
Status: Enrolling
Updated:  10/3/2017
Stony Brook Univeristy
mi
from
Stony Brook, NY
Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking and Quality of Life in MS
Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking Performance and Quality of Life in Individuals With Multiple Sclerosis: A Pilot Study
Status: Enrolling
Updated: 10/3/2017
Stony Brook Univeristy
mi
from
Stony Brook, NY
Click here to add this to my saved trials
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated:  10/3/2017
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated: 10/3/2017
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated:  10/3/2017
University of California Davis Cancer Center
mi
from
Davis, CA
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated: 10/3/2017
University of California Davis Cancer Center
mi
from
Davis, CA
Click here to add this to my saved trials
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated:  10/3/2017
Contra Costa Regional Medical Center
mi
from
Martinez, CA
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated: 10/3/2017
Contra Costa Regional Medical Center
mi
from
Martinez, CA
Click here to add this to my saved trials
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated:  10/3/2017
St. Anthony Central Hospital
mi
from
Denver, CO
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated: 10/3/2017
St. Anthony Central Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated:  10/3/2017
University of Colorado Cancer Center at University of Colorado Health Sciences Center
mi
from
Denver, CO
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated: 10/3/2017
University of Colorado Cancer Center at University of Colorado Health Sciences Center
mi
from
Denver, CO
Click here to add this to my saved trials
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated:  10/3/2017
Montrose Memorial Hospital Cancer Center
mi
from
Montrose, CO
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated: 10/3/2017
Montrose Memorial Hospital Cancer Center
mi
from
Montrose, CO
Click here to add this to my saved trials
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated:  10/3/2017
St. Anthony North Hospital
mi
from
Westminster, CO
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated: 10/3/2017
St. Anthony North Hospital
mi
from
Westminster, CO
Click here to add this to my saved trials
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated:  10/3/2017
Exempla Lutheran Medical Center
mi
from
Wheat Ridge, CO
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated: 10/3/2017
Exempla Lutheran Medical Center
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated:  10/3/2017
Piedmont Hospital
mi
from
Atlanta, GA
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated: 10/3/2017
Piedmont Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated:  10/3/2017
CCOP - Atlanta Regional
mi
from
Atlanta, GA
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated: 10/3/2017
CCOP - Atlanta Regional
mi
from
Atlanta, GA
Click here to add this to my saved trials
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated:  10/3/2017
Northside Hospital Cancer Center
mi
from
Atlanta, GA
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated: 10/3/2017
Northside Hospital Cancer Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated:  10/3/2017
Saint Joseph's Hospital of Atlanta
mi
from
Atlanta, GA
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated: 10/3/2017
Saint Joseph's Hospital of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated:  10/3/2017
WellStar Cobb Hospital
mi
from
Austell, GA
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated: 10/3/2017
WellStar Cobb Hospital
mi
from
Austell, GA
Click here to add this to my saved trials
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated:  10/3/2017
Charles B. Eberhart Cancer Center at DeKalb Medical Center
mi
from
Decatur, GA
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated: 10/3/2017
Charles B. Eberhart Cancer Center at DeKalb Medical Center
mi
from
Decatur, GA
Click here to add this to my saved trials
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated:  10/3/2017
Gwinnett Medical Center
mi
from
Lawrenceville, GA
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated: 10/3/2017
Gwinnett Medical Center
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated:  10/3/2017
Kennestone Cancer Center at Wellstar Kennestone Hospital
mi
from
Marietta, GA
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated: 10/3/2017
Kennestone Cancer Center at Wellstar Kennestone Hospital
mi
from
Marietta, GA
Click here to add this to my saved trials
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated:  10/3/2017
Southern Regional Medical Center
mi
from
Riverdale, GA
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated: 10/3/2017
Southern Regional Medical Center
mi
from
Riverdale, GA
Click here to add this to my saved trials
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated:  10/3/2017
Cardinal Bernardin Cancer Center at Loyola University Medical Center
mi
from
Maywood, IL
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated: 10/3/2017
Cardinal Bernardin Cancer Center at Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated:  10/3/2017
Regional Cancer Center at Memorial Medical Center
mi
from
Springfield, IL
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated: 10/3/2017
Regional Cancer Center at Memorial Medical Center
mi
from
Springfield, IL
Click here to add this to my saved trials
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated:  10/3/2017
St. Francis Hospital and Health Centers
mi
from
Beech Grove, IN
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated: 10/3/2017
St. Francis Hospital and Health Centers
mi
from
Beech Grove, IN
Click here to add this to my saved trials
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated:  10/3/2017
McFarland Clinic, PC
mi
from
Ames, IA
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated: 10/3/2017
McFarland Clinic, PC
mi
from
Ames, IA
Click here to add this to my saved trials
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated:  10/3/2017
Baton Rouge General Regional Cancer Center
mi
from
Baton Rouge, LA
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Status: Enrolling
Updated: 10/3/2017
Baton Rouge General Regional Cancer Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials